478 related articles for article (PubMed ID: 1628156)
1. Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol.
Karoum F; Egan MF
Br J Pharmacol; 1992 Mar; 105(3):703-7. PubMed ID: 1628156
[TBL] [Abstract][Full Text] [Related]
2. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model.
Karoum F; Chrapusta SJ; Egan MF
J Neurochem; 1994 Sep; 63(3):972-9. PubMed ID: 7914228
[TBL] [Abstract][Full Text] [Related]
3. Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats.
Invernizzi R; Morali F; Pozzi L; Samanin R
Br J Pharmacol; 1990 Aug; 100(4):774-8. PubMed ID: 2207499
[TBL] [Abstract][Full Text] [Related]
4. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
Meltzer HY; Chai BL; Thompson PA; Yamamoto BK
J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957
[TBL] [Abstract][Full Text] [Related]
5. Effects of acute and chronic clozapine and haloperidol administration on 3-methoxytyramine accumulation in rat prefrontal cortex, nucleus accumbens and striatum.
Egan MF; Karoum F; Wyatt RJ
Eur J Pharmacol; 1991 Jun; 199(2):191-9. PubMed ID: 1954977
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens.
Ichikawa J; Meltzer HY
J Pharmacol Exp Ther; 1991 Jan; 256(1):348-57. PubMed ID: 1703232
[TBL] [Abstract][Full Text] [Related]
7. gamma-Butyrolactone-sensitive and -insensitive dopamine release, and their relationship to dopamine metabolism in three rat brain regions.
Chrapusta SJ; Karoum F; Egan MF; Wyatt RJ
Eur J Pharmacol; 1992 Nov; 222(1):129-35. PubMed ID: 1468488
[TBL] [Abstract][Full Text] [Related]
8. Haloperidol and clozapine increase intraneuronal dopamine metabolism, but not gamma-butyrolactone-resistant dopamine release.
Chrapusta SJ; Karoum F; Egan MF; Wyatt RJ
Eur J Pharmacol; 1993 Mar; 233(1):135-42. PubMed ID: 8472742
[TBL] [Abstract][Full Text] [Related]
9. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism.
Gray AM; Connick JH
Eur J Pharmacol; 1998 Dec; 362(2-3):127-36. PubMed ID: 9874162
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of amfonelic acid on the haloperidol- and clozapine-induced increase in extracellular DOPAC in the nucleus accumbens and the striatum.
Rivest R; Marsden CA
Synapse; 1992 Jan; 10(1):71-8. PubMed ID: 1371367
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol.
Rivest R; Marsden CA
Br J Pharmacol; 1991 Sep; 104(1):234-8. PubMed ID: 1786513
[TBL] [Abstract][Full Text] [Related]
12. The effect of chronic clozapine and haloperidol on basal dopamine release and metabolism in rat striatum and nucleus accumbens studied by in vivo microdialysis.
Ichikawa J; Meltzer HY
Eur J Pharmacol; 1990 Feb; 176(3):371-4. PubMed ID: 2184042
[TBL] [Abstract][Full Text] [Related]
13. Alterations in dopamine metabolism by intraperitoneal ethanol in rats selected for high and low ethanol preference: a 3-methoxytyramine study.
Honkanen A; Chrapusta SJ; Karoum F; Korpi ER
Alcohol; 1994; 11(4):323-8. PubMed ID: 7945987
[TBL] [Abstract][Full Text] [Related]
14. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study.
Moghaddam B; Bunney BS
J Neurochem; 1990 May; 54(5):1755-60. PubMed ID: 1969939
[TBL] [Abstract][Full Text] [Related]
15. Halothane attenuated haloperidol and enhanced clozapine-induced dopamine release in the rat striatum.
Adachi YU; Aramaki Y; Satomoto M; Higuchi H; Watanabe K
Neurochem Int; 2003 Jul; 43(2):113-9. PubMed ID: 12620279
[TBL] [Abstract][Full Text] [Related]
16. Haloperidol given chronically decreases basal dopamine in the prefrontal cortex more than the striatum or nucleus accumbens as simultaneously measured by microdialysis.
Hernandez L; Hoebel BG
Brain Res Bull; 1989 Apr; 22(4):763-9. PubMed ID: 2736403
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of dopamine metabolism in rat brain frontal cortex: a common effect of chronically administered antipsychotic drugs.
Mefford IN; Roth KA; Agren H; Barchas JD
Brain Res; 1988 Dec; 475(2):380-4. PubMed ID: 2905626
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of chronic treatment with haloperidol and clozapine on the level of preprosomatostatin mRNA in the striatum, nucleus accumbens, and frontal cortex of the rat.
Salin P; Mercugliano M; Chesselet MF
Cell Mol Neurobiol; 1990 Mar; 10(1):127-44. PubMed ID: 1970756
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of certain dopaminergic drugs on the striatal concentration of dopamine metabolites, with special reference to 3-methoxytramine.
Ponzio F; Achilli G; Perego C; Algeri S
Neurosci Lett; 1981 Nov; 27(1):61-7. PubMed ID: 7329624
[TBL] [Abstract][Full Text] [Related]
20. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
Ichikawa J; Meltzer HY
Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]